NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market on Thursday that revenues for the first quarter increased more than 2 percent year over year on a GAAP basis, or more than 4 percent excluding currency effects.

The Carlsbad, Calif.-based firm said that for the three months ended March 31, GAAP revenues totaled $962.5 million, up from $939.1 million, and surpassing the consensus Wall Street estimate of $958.6 million.

On a non-GAAP basis the company reported $962.9 million in revenues, up 3 percent from $939.0 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.